The new pandemic treaty draft which will be considered at the World Health Organization’s next Intergovernmental Negotiating Body meetings in November and December is facing questions and opposition.
Advocates are encouraged that the new draft continues to include text on intellectual property waivers — despite fierce opposition from the pharmaceutical industry — and other text to achieve equity but said the language remains vague and weak on enforcement.
Mohga Kamal-Yanni, policy co-lead of the People’s Vaccine Alliance, said the current wording overall “contains too few obligations to ensure governments take these essential measures.”